Companies / MRK vs ZTS
MRK vs ZTS: Merck and Zoetis
Merck (MRK) reported $65.0B in revenue against a 28.1% net margin, while Zoetis (ZTS) reported $9.5B at a 28.2% net margin, most recently.
| Metric | MRK | ZTS |
|---|---|---|
| Revenue | $65.0B | $9.5B |
| Net Income | $18.3B | $2.7B |
| Gross Margin | 74.8% | 71.8% |
| Operating Margin | — | — |
| EPS (Diluted) | $7.28 | $6.02 |
| Free Cash Flow | $12.4B | $2.3B |
| Total Debt | $49.3B | $9.0B |
| P/E Ratio | 14.5× | 20.9× |
| P/B Ratio | n/m | 16.1× |
| Stock Price | $147.90 | $82.13 |
Free: last 5 years
| Fiscal year | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $48.7B | $59.3B | $60.1B | $64.2B | $65.0B |
| ZTS Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $7.8B | $8.1B | $8.5B | $9.3B | $9.5B |